Secretome Therapeutics to Present at the 2026 J.P. Morgan Healthcare Conference

Secretome Therapeutics, a clinical-stage biotechnology company based in Plano, Texas, announced it will present at the 2026 J.P. Morgan Healthcare Conference in San Francisco January 12–15, with its session scheduled for January 15, 2026.The company plans to showcase its proprietary neonatal cardiac progenitor cell (nCPC) platform and discuss progress in its clinical programs, including updates on its lead asset, STM-01, which is in ongoing Phase 1 trials for heart failure. Company leadership will also be available for one-on-one investor and partner meetings during the event.

Learn More